Skip to content

Role of homoeopathic treatment in cases of pain in shoulder

Utility of individualized homoeopathic medicine in managing pain of adhesive capsulitis : A prospective open label observational clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019121
Enrollment
40
Registered
2019-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Individulaised Homeopathic Medicine: Initial dose: 4 globules,frequency: BD,route of administration: oral, duration of therapy: 2 month Control Intervention1: Nil: Not applicable

Sponsors

DG CCRH
Lead Sponsor
Officer in Charge
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of both gender 2.Patients within age of 30-70 years 3.Patients presenting with clinical symptoms of adhesive capsulitis of one or both shoulder 4.Patients in the stage of acute/freezing/painful stage and adhesive/frozen stiffening phase of adhesive capsulitis 5.Patient willing to give informed consent

Exclusion criteria

Exclusion criteria: 1.Severe degeneration of shoulder joint with marked joint narrowing with recent shoulder surgery within last 6 months 2.Deformity of shoulder ( >12o); evidence by imaging or other evidences and requiring surgical intervention 3.Self-reported joint disorders (e.g. inflammatory joint disease, specific arthropathy, severe axis deviations or instabilities, joint or skin infections, joint prosthesis of the upper limbs) other than adhesive capsulitis 4.Cases with other systemic diseases and with any vital organ failure and any self-reported immune-compromised states 5.Patients unwilling to give informed consent.

Design outcomes

Primary

MeasureTime frame
Primary endpoint Pain VAS score at the end of 2 months treatment. Timepoint: Primary endpoint Pain VAS score at the end of 2 months treatment.

Secondary

MeasureTime frame
Secondary endpoint â?¢ ORIDL and WHOQOL scale assessment after 2 months treatment. Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Gurudev Choubey

Clinical Research Unit(Homoeopathy)

cruslg@gmail.com9475916907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026